Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Objetivo
Evaluar la utilidad clnica de las medidas de
Medidas de asociacin
Generalidades
Las medidas de asociacin tiene por objeto
Medidas de asociacin
Ejemplo: Estudio Magpie
Eclampsia
+
MgSo4
TOTAL
40
5 015
5 055
95
4 959
5 055
136
9 974
10 110
TOTAL
The Magpie Trial Collaborative Group. Do women with pre-eclampsi, and their babies, benefit from
magnsium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 18771890.
Riesgo de expuestos(pe):
055=0.008
40/5
Riesgo de no expuestos(pne):
055= 0.019
96/ 5
Eclampsia
MgSo4
TOTAL
40
5 015
5 055
95
4 959
5 055
136
9 974
10 110
TOTAL
The Magpie Trial Collaborative Group. Do women with pre-eclampsi, and their babies, benefit from
magnsium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 18771890.
MgSo4
TOTAL
40
5 015
5 055
95
4 959
5 055
136
9 974
10 110
TOTAL
The Magpie Trial Collaborative Group. Do women with pre-eclampsi, and their babies, benefit from
magnsium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 18771890.
Riesgo relativo(RR):
0.42
0.008/0.019=
MgSo4
TOTAL
40
5 015
5 055
95
4 959
5 055
136
9 974
10 110
TOTAL
The Magpie Trial Collaborative Group. Do women with pre-eclampsi, and their babies, benefit from
magnsium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 18771890.
Riesgo relativo
Riesgo relativo(RR):
0.008/0.019= 0.42
MgSo4
TOTAL
40
5 015
5 055
95
4 959
5 055
136
9 97410
10 110
TOTAL
The Magpie Trial Collaborative Group. Do women with pre-eclampsi, and their babies, benefit from
magnsium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 18771890.
MgSo4
TOTAL
40
5 015
5 055
95
4 959
5 055
136
9 97410
10 110
TOTAL
The Magpie Trial Collaborative Group. Do women with pre-eclampsi, and their babies, benefit from
magnsium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 18771890.
ad
=
bc
RR
a+b
=
c+d
=
c
0.0018
=
b
d
OR o RRI= 0.42
* Cuando el desenlace es
infrecuente, el RR = OR
0.019
40
96
5 015
4 959
NNT= 1 / RAR
NNT ideal=1
Si no hay diferencias en la reduccin del riesgo, el
NNT es infinito. (NNT= 1/5%-5% =1/0)
NNT= 1 / 0.019-0.008= 1/ 0.011= 91
Se requieren tratar a 91 pacientes con MgSO4
para prevenir la aparicin de una eclampsia
Estudio Mapgie
Conclusiones
RR= 0.008/0.019=0.8%/1.9%= 0.42
Estudio Mapgie
Conclusiones
RR= 0.008/0.019=0.8%/1.9%= 0.42
-0.0132
NNH= 76
Estudio Mapgie
Conclusiones
NNT= 91
Por cada 91 pacientes tratadas se previene 1 eclampsia
NNH= 76
Por cada 76 pacientes tratadas ocurre 1 caso de
debilidad muscular
Relacin riesgo beneficio=91/76= 1.2
Por cada 1 000 pacientes con preeclampsia tratadas
con MgSO4, se prevendrn 11 casos de eclampsia y
ocurrirn 13 casos de debilidad muscular
Por cada 10 casos de eclampsia que se previenen con
el uso de MgSO4 ocurren 12 casos de debilidad
muscular
Cncer de mama
Riesgo de historia familiar
Pacientes menores de 50 aos con historia familiar de
Calle FF, Martin LM, Thun Mj, et al. Family history, age and risk of fatal breast cancer. Am J Epidemiol 1993;
63: 6090-6101.
Conclusiones
Las